Long-Term Evaluation of Biliary Reflux on Esogastric Mucosae after One-Anastomosis Gastric Bypass and Esojejunostomy in Rats.

Bariatric surgery Biliary reflux Cancer Metaplasia Mini gastric bypass Morbid obesity One anastomosis gastric bypass

Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 5 3 2020
medline: 15 4 2021
entrez: 5 3 2020
Statut: ppublish

Résumé

One-anastomosis gastric bypass/mini-gastric bypass (OAGB/MGB) remains controversial because it may cause chronic biliary reflux (BR). The risk of developing esogastric cancer due to BR after OAGB/MGB is based on the results of experimental rat studies using esojejunostomy (EJ). The aim of this study was to analyze the potential long-term consequences of BR on the esogastric mucosae in OAGB/MGB-operated rats and to compare these results to those from the use of EJ. Wistar rats received OAGB/MGB (n = 16), EJ (n = 16), and sham (n = 8) operations. Mortality and weight changes were evaluated throughout the experiment. BR was measured using magnetic resonance imaging (MRI). Rats received follow-ups for 30 weeks. A double-blinded histological analysis was performed in the esogastric segments. BR was diagnosed in OAGB/MGB and EJ rats using the MRI technique; no BR occurred in the sham group. After a 30-week follow-up, no incidences of dysplasia or cancer were observed in the three groups. Additionally, esophageal intestinal metaplasia and mucosal ulcerations were observed in 41.7% and 50% of EJ rats, respectively, and no incidences of these conditions were observed in OAGB/MGB and sham rats. The incidence of esophagitis was significantly higher and more severe in the EJ group compared to those in the OAGB/MGB and sham groups (EJ = 100%, OAGB/MGB = 16.7%, sham = 8.3%; p < 0.001). After a 30-week follow-up period, OAGB/MGB rats did not develop any precancerous or cancerous lesions when more than 40% of EJ rats had intestinal metaplasia.

Sections du résumé

BACKGROUND BACKGROUND
One-anastomosis gastric bypass/mini-gastric bypass (OAGB/MGB) remains controversial because it may cause chronic biliary reflux (BR). The risk of developing esogastric cancer due to BR after OAGB/MGB is based on the results of experimental rat studies using esojejunostomy (EJ). The aim of this study was to analyze the potential long-term consequences of BR on the esogastric mucosae in OAGB/MGB-operated rats and to compare these results to those from the use of EJ.
METHODS METHODS
Wistar rats received OAGB/MGB (n = 16), EJ (n = 16), and sham (n = 8) operations. Mortality and weight changes were evaluated throughout the experiment. BR was measured using magnetic resonance imaging (MRI). Rats received follow-ups for 30 weeks. A double-blinded histological analysis was performed in the esogastric segments.
RESULTS RESULTS
BR was diagnosed in OAGB/MGB and EJ rats using the MRI technique; no BR occurred in the sham group. After a 30-week follow-up, no incidences of dysplasia or cancer were observed in the three groups. Additionally, esophageal intestinal metaplasia and mucosal ulcerations were observed in 41.7% and 50% of EJ rats, respectively, and no incidences of these conditions were observed in OAGB/MGB and sham rats. The incidence of esophagitis was significantly higher and more severe in the EJ group compared to those in the OAGB/MGB and sham groups (EJ = 100%, OAGB/MGB = 16.7%, sham = 8.3%; p < 0.001).
CONCLUSIONS CONCLUSIONS
After a 30-week follow-up period, OAGB/MGB rats did not develop any precancerous or cancerous lesions when more than 40% of EJ rats had intestinal metaplasia.

Identifiants

pubmed: 32130650
doi: 10.1007/s11695-020-04521-4
pii: 10.1007/s11695-020-04521-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2598-2605

Auteurs

Leïla M'Harzi (L)

General and Digestive Surgery Unit, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.
INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

Jean-Marc Chevallier (JM)

General and Digestive Surgery Unit, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.
INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

Anais Certain (A)

INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

Gwennhaël Autret (G)

INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

Guillaume Levenson (G)

General and Digestive Surgery Unit, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.
INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

David Louis (D)

INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

Tigran Poghosyan (T)

General and Digestive Surgery Unit, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.
INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

Arthur Berger (A)

INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.
Department of Hepato-gastroenterology and Endoscopy, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.

Gabriel Rahmi (G)

INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.
Department of Hepato-gastroenterology and Endoscopy, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.

Chloé Broudin (C)

INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.
Department of Pathology, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.

Olivier Clément (O)

INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.
Department of Radiology, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.

Richard Douard (R)

General and Digestive Surgery Unit, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France.
INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

Bertrand Tavitian (B)

INSERM 970, Équipe 2, PARCC, HEGP, Paris, France.

Matthieu Bruzzi (M)

General and Digestive Surgery Unit, Georges Pompidou, AP-HP University Hospital, 20 Rue Leblanc, 75908, Paris Cedex 15, France. matthieu.bruzzi@aphp.fr.
INSERM 970, Équipe 2, PARCC, HEGP, Paris, France. matthieu.bruzzi@aphp.fr.
Service de chirurgie générale et digestive, Hôpital européen Georges Pompidou, 20 rue Leblanc, 75015, Paris, France. matthieu.bruzzi@aphp.fr.

Articles similaires

Humans Meals Time Factors Female Adult
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH